AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 0 | – | 0.00% | – |
Q2 2023 | $0 | – | 0 | – | 0.00% | – |
Q1 2023 | $0 | – | 0 | – | 0.00% | – |
Q4 2022 | $0 | – | 0 | – | 0.00% | – |
Q3 2022 | $0 | – | 0 | – | 0.00% | – |
Q2 2022 | $0 | – | 0 | – | 0.00% | – |
Q1 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2021 | $106,000 | +2550.0% | 2,800 | +2492.6% | 0.01% | – |
Q3 2021 | $4,000 | -42.9% | 108 | 0.0% | 0.00% | – |
Q2 2021 | $7,000 | +16.7% | 108 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -33.3% | 108 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $9,000 | +28.6% | 108 | +8.0% | 0.00% | 0.0% |
Q3 2020 | $7,000 | – | 100 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | – | 0 | – | 0.00% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Q1 2019 | $0 | – | 0 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |